Thanks Moosey, yes had seen that\thank you.The following is...

Thanks Moosey, yes had seen that\thank you.

The following is interesting from China.

What are some good projects in Australia's "Global Biotechnology Capital"? (note you will have to translate on opening link)

https://www.hotbak.net/key/%E6%BE%B3%E5%A4%A7%E5%88%A9%E4%BA%9A%E5%85%A8%E7%90%83%E7%94%9F%E7%89%A9%E6%8A%80%E6%9C%AF%E4%B9%8B%E9%83%BD%E9%83%BD%E6%9C%89%E5%93%AA%E4%BA%9B%E5%A5%BD%E9%A1%B9%E7%9B%AE.html

Biotechnology
Biotron Limited (ASX: BIT) is a listed biotechnology company based in Sydney, Australia, developing new drugs for severe viral diseases. The company is developing and commercializing a new small molecule drug for the treatment of various viral diseases. Scientists have found the viral protein of Viroporin in many viruses, and it is essential for the pathogenicity of the virus. Biotron's core technology is to target viroporins called viroporins. The company has developed a focused library of viroporin inhibitors and screening assays for key viral targets.The company's main drug is BIT225, which focuses on HIV-1 and hepatitis C virus (HCV), currently in phase II clinical phase.In addition to its clinical development plan for BIT225, Biotron also has drug development plans for other viruses, including dengue fever and respiratory viruses, Ebola and Zika virus.Biotron is seeking partnerships to further develop the clinical development of its projects and is also cooperating in the commercialization of antiviral assets.

I know it's a rehashed script from March investment expo published again yesterday, but it would be nice to see some chinese investors come through.